The purpose of this research is to assess the impact of CBD on the effects of THC.
Some evidence indicates that cannabidiol (CBD), a non-intoxicating cannabis component, might mitigate certain effects of THC. This study will examine possible roles for CBD in modulating THC's adverse and analgesic effects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
30
UCLA Center for Cannabis and Cannabinoids
Los Angeles, California, United States
RECRUITINGSubject-rated drug effects of abuse liability
Subject ratings of "Good Drug Effect" as measured using a visual analog scale (1-100 mm)
Time frame: 3 hours
Analgesia as measured using the Cold Pressor Test
Pain threshold assessed using the Cold Pressor Test (percent baseline)
Time frame: 3 hours
Behavioral task performance as assessed by the DRUID App Score
Trough composite scores on the DRUID App
Time frame: 3 hours
Pharmacokinetics of THC
Peak plasma levels of THC (ng/ml)
Time frame: 3 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Vaporized CBD (40 mg)
Vaporized CBD (80 mg)